TrialMax® is a proven eCOA platform backed by 20 years of industry expertise. It can be used for home or site-based ePROs, eClinROs, eObsROs, and collection of integrated wearable and sensor data.
Other content in this Stream
Signant Health and ActiGraph simplify clinical trial activity and sleep monitoring for patients, sites, and sponsors with integration
The integration of Signant Health’s TrialMax® eCOA platform with ActiGraph’s CentrePoint system and research-grade wearables marries ease-of-use with real-time data and insights
Signant Health's eCOA and Endpoint Quality Solutions for Orphan Disease Research
Signant Health provides a complete eCOA and Endpoint Quality solution that is user-friendly & allows you to capture data on clinician & patient-rated outcome measures & event diaries, on-site or home
Signant Health Raises the Bar in Ulcerative Colitis Trials with eCOA
Q&A with Katie Garner, Signant Health: Using eCOA in Ulcerative Colitis Trials for Seamless MAYO Score Calculation
Signant Health's Endpoint Quality Solution
Take an evidence-based approach to ensuring endpoint quality.
Patient-Facing Technologies in Clinical Research: Myths vs. Reality
This webinar explores misconceptions surrounding technologies like eConsent and BYOD ePRO with industry experts, helping you make informed decisions and improve your clinical trial success.
TrialMax eCOA - Signant Health
When it comes to eCOA – the patient experience matters. Watch this video to learn more about TrialMax.
Bill Byrom Welcomes You to the 2019 eCOA Forum
Bill Byrom welcomes you to the 2019 eCOA Forum. Join us Dec 10-11, 2019 in Philadelphia.
Managing eCOA Data - Principles and Best Practices
9 KPI Dashboards & Reports No eCOA Study Should Be Without
eCOA Design and Implementation Overview
Electronic Clinical Outcome Assessments (eCOA) - An Introductory Guide
Signant Health Partner Program
Become a CRO partner today. Sponsors what to know what your competitive edge is, so let's show them. We'll make sure you are distinguished and trusted for delivering across the Signant portfolio.
Electronic Version of the Neurostatus-EDSS Improves MS Trials
University Hospital Basel, Novartis and Signant Health (formerly CRF Health) recently published our experience data on the use of the eEDSS obtained from two phase III Multiple Sclerosis trials.
Improving Data Quality in Dermatology Clinical Trials
This webinar discusses the unique data collection challenges faced by dermatology clinical trials and how they can be improved with eCOA, rater training and effective analytics.
Advantage of ePRO for Pain Studies
Chris Clancy looks at ePRO deployment in three types of pain studies, discussing the advantages and offering advice related to recall bias effects and FDA PRO guidance. Recorded September 17, 2009.
Neuroscience eClinRO Solution
Get to know our Neuroscience eClinRO solution. An advanced solution that enhances the accuracy and reliability of clinician-rated endpoint data.
Making eCOA Accessible for All Populations
eCOA Design Considerations: Reminders and Alarms
Understanding the Benefits of eCOA in Oncology Clinical Trials